USP22 and colorectal cancer: Notably, human tumor gene expression data generated by the TCGA Research Network (http://cancergenome.nih.gov/;22) implied that a significant proportion of colorectal cancer (22%) and breast cancer patients (26%) display low USP22 expression (Fig. S1A).